Business Description
AS Latvijas Juras medicinas centrs
ISIN : LV0000100741
Total Employee Number:
346Compare
Compare
Traded in other countries / regions
LJM1R.Latvia IPO Date
1998-05-11Description
AS Latvijas Juras medicinas centrs is a private certified medical institution in Latvia providing outpatient and inpatient healthcare services through qualified staff and modern equipment. Its core activities include hospital services, orthopaedic retail, medical and dental practice, human health and residential care, social work activities, and physical well-being services. It operates the Women's Health Clinic, offering gynecological consultations, pregnancy care, diagnostics, postpartum services, gynecological care for girls, and surgery. The centre also provides vaccination, rehabilitation, a Multiple Sclerosis Center, medical commission, home visits, laboratory services, physical medicine and massage, therapeutic procedures, medical treatment, and anesthesia and intensive care.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.73 | |||||
Interest Coverage | 10.36 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.22 | |||||
Beneish M-Score | -3.36 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2 | |||||
3-Year EBITDA Growth Rate | -7.4 | |||||
3-Year EPS without NRI Growth Rate | -27.3 | |||||
3-Year Book Growth Rate | -2.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 63.23 | |||||
9-Day RSI | 57.79 | |||||
14-Day RSI | 53.25 | |||||
3-1 Month Momentum % | -11.24 | |||||
6-1 Month Momentum % | 25.4 | |||||
12-1 Month Momentum % | 36.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.86 | |||||
Quick Ratio | 0.79 | |||||
Cash Ratio | 0.63 | |||||
Days Inventory | 5.33 | |||||
Days Sales Outstanding | 4.22 | |||||
Days Payable | 15.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.28 | |||||
Dividend Payout Ratio | 0.33 | |||||
3-Year Dividend Growth Rate | -20.6 | |||||
Forward Dividend Yield % | 1.28 | |||||
5-Year Yield-on-Cost % | 1.28 | |||||
Shareholder Yield % | 1.28 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 7.14 | |||||
Operating Margin % | 1.11 | |||||
Net Margin % | 2.34 | |||||
EBITDA Margin % | 4.13 | |||||
FCF Margin % | -2.03 | |||||
OCF Margin % | -0.17 | |||||
ROE % | 3.86 | |||||
ROA % | 2.7 | |||||
ROIC % | 1.21 | |||||
3-Year ROIIC % | -27.06 | |||||
ROC (Joel Greenblatt) % | 1.55 | |||||
ROCE % | 1.64 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 26.09 | |||||
PE Ratio without NRI | 26.09 | |||||
Shiller PE Ratio | 22.79 | |||||
PS Ratio | 0.61 | |||||
PB Ratio | 0.99 | |||||
Price-to-Tangible-Book | 0.99 | |||||
EV-to-EBIT | 44.63 | |||||
EV-to-EBITDA | 11.97 | |||||
EV-to-Revenue | 0.49 | |||||
EV-to-FCF | -24.34 | |||||
Price-to-GF-Value | 1 | |||||
Price-to-Projected-FCF | 1.43 | |||||
Price-to-Median-PS-Value | 0.92 | |||||
Price-to-Graham-Number | 1.07 | |||||
Earnings Yield (Greenblatt) % | 2.24 | |||||
FCF Yield % | -3.35 | |||||
Forward Rate of Return (Yacktman) % | 18.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AS Latvijas Juras medicinas centrs Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 10.287 | ||
| EPS (TTM) (€) | 0.299 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.11 | ||
| 3-Year Sortino Ratio | -0.17 | ||
| Volatility % | 49.96 | ||
| 14-Day RSI | 53.25 | ||
| 14-Day ATR (€) | 0.042432 | ||
| 20-Day SMA (€) | 7.8 | ||
| 12-1 Month Momentum % | 36.21 | ||
| 52-Week Range (€) | 5.8 - 9.5 | ||
| Shares Outstanding (Mil) | 0.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AS Latvijas Juras medicinas centrs Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AS Latvijas Juras medicinas centrs Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 0.100000 Cash Dividend | 2025-08-26 | 6.60 (+0.00%) |
Show
Entries
AS Latvijas Juras medicinas centrs Frequently Asked Questions
What is AS Latvijas Juras medicinas centrs(ORSE:LJM1R)'s stock price today?
The current price of ORSE:LJM1R is €7.80. The 52 week high of ORSE:LJM1R is €9.50 and 52 week low is €5.80.
When is next earnings date of AS Latvijas Juras medicinas centrs(ORSE:LJM1R)?
The next earnings date of AS Latvijas Juras medicinas centrs(ORSE:LJM1R) is .
Does AS Latvijas Juras medicinas centrs(ORSE:LJM1R) pay dividends? If so, how much?
The Dividend Yield %  of AS Latvijas Juras medicinas centrs(ORSE:LJM1R) is 1.28% (As of Today), Highest Dividend Payout Ratio of AS Latvijas Juras medicinas centrs(ORSE:LJM1R) was 1.62. The lowest was 0.06. And the median was 0.36. The  Forward Dividend Yield % of AS Latvijas Juras medicinas centrs(ORSE:LJM1R) is 1.28%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on AS Latvijas Juras medicinas centrs
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers